Tata Motors’ Nov global sales down 19.91%; but JLR does well

14 Dec 2013

1

Indian carmaker Tata Motors today said its global vehicle sales declined by 19.91 per cent to 81,957 units in November, compared to the year-ago period. The company had sold 1,02,337 units in the corresponding period of 2012.

Global sales of all passenger vehicles in November stood at 50,703 units, down 4.49 per cent, from 53,089 in November 2012, Tata Motors said in a statement.

Cumulative global sales for the FY 2014 too declined 14 per cent to 674,729 units during the period.

Global sales of all Tata Motors commercial vehicles and the Tata Daewoo range declined 36.5 per cent to 31,254 units on the back of low demand in the global markets.

Cumulative commercial vehicles sales for the fiscal were down 20 per cent to 306,532 units as well.

Sales of luxury brand Jaguar Land Rover continued to provide the bright spot, rising by 15.31 per cent to 39,956 units during November, as compared to 34,649 in the same month last year.

Latest articles

Sigma Advanced to acquire UK aerospace supplier Bromford for ₹153 crore

Sigma Advanced to acquire UK aerospace supplier Bromford for ₹153 crore

Akasa Air plans ₹1,050 crore fundraising to support growth amid higher costs

Akasa Air plans ₹1,050 crore fundraising to support growth amid higher costs

AI startup Reflection signs over $1 billion computing deal with Nebius

AI startup Reflection signs over $1 billion computing deal with Nebius

Tata Power explores $450 million overseas loan for business operations

Tata Power explores $450 million overseas loan for business operations

TCS wins technology contract for New York JFK Airport’s $19 billion terminal

TCS wins technology contract for New York JFK Airport’s $19 billion terminal

South Korean firms unveil $195 billion investment in AI and advanced industries

South Korean firms unveil $195 billion investment in AI and advanced industries

HCLTech wins $1.14 billion AI transformation deal with European client

HCLTech wins $1.14 billion AI transformation deal with European client

Microsoft launches Frontier to help enterprises accelerate AI adoption

Microsoft launches Frontier to help enterprises accelerate AI adoption

AstraZeneca signs up to $1.77 billion CSPC deal for kidney disease drugs

AstraZeneca signs up to $1.77 billion CSPC deal for kidney disease drugs